Megola, Inc. (OTCPK:MGON) entered into definitive agreement to acquire License of Intellectual Property, Product Lines, Manufacturing & Other Assets of Medesol Global Inc. for $0.25 million on September 20, 2022. Medesol Global Inc receives 25,000 Restricted PFD D shares with a stated value of $10 per share. Megola's BOD will also determine future royalties to Medesol Global per specific product sales generated.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00469 USD | -4.29% | -4.08% | +95.83% |
1st Jan change | Capi. | |
---|---|---|
+95.83% | 1.43M | |
-17.56% | 39.45B | |
+3.70% | 18.48B | |
-25.78% | 6.09B | |
+6.67% | 6.02B | |
-5.41% | 3.04B | |
+8.10% | 2.43B | |
-9.44% | 1.9B | |
+26.47% | 950M | |
-3.72% | 620M |
- Stock Market
- Equities
- MGON Stock
- News Megola, Inc.
- Megola, Inc. entered into definitive agreement to acquire License of Intellectual Property, Product Lines, Manufacturing & Other Assets of Medesol Global Inc. for $0.25 million.